Navigation Links
AIDS Vaccines: Where Do We Go From Here?
Date:7/28/2008

The International AIDS Vaccine Initiative (IAVI) and Key Thought Leaders Explore Critical Next Steps for AIDS Vaccine Research at the 17th International AIDS Conference in Mexico City

NEW YORK, July 28 /PRNewswire-USNewswire/ -- The following was released today by the International AIDS Vaccine Initiative:

WHAT:

Today, AIDS vaccine research is at a pivotal moment. Just ten months ago, the second AIDS vaccine candidate to reach late-stage testing failed. In the wake of this disappointment, some skeptics have argued that an AIDS vaccine may not be possible and that resources dedicated to its development should be directed instead towards treating HIV-infected individuals. Now is the time to take a hard look at the toughest questions currently facing AIDS vaccine researchers. How should the finite resources for AIDS vaccine research be prioritized? How can the toughest scientific questions facing AIDS vaccine researchers be tackled? What criteria should be used to decide which vaccine candidates merit further testing, and which should be dropped? How do you continue to sustain much-needed support for a preventive vaccine that may take decades to develop?

In its biennial AIDS Vaccine Blueprint: A Challenge to the Field, a Roadmap for Progress, IAVI will put forth a series of concrete recommendations and milestones that will guide research to answer the critical scientific questions that have hampered AIDS vaccine development to date.

WHY:

The AIDS pandemic is one of the greatest global health crises of our time. In the 25 years since HIV was first identified as the cause of AIDS, an estimated 25 million people have died of the disease and 33 million more are currently living with HIV. Almost 7,000 people become newly infected with HIV everyday, and for every two people who start antiretroviral therapy, another five become newly infected with HIV. While a preventive vaccine is the best long-term solution to the pandemic, much still remains to be done to discover and make a vaccine accessible globally.

WHO:

Seth Berkley, MD, CEO and President, International AIDS Vaccine Initiative (IAVI)

Peter Piot, MD, Executive Director, UNAIDS and Under Secretary-General, United Nations

Alan Bernstein, MD, Executive Director, Global HIV Vaccine Enterprise

Omu Anzala, MD, Associate Professor, University of Nairobi School of Medicine

WHERE:

Media Centre, Room 2

WHEN:

Tuesday, August 5 (9:00AM to 9:45AM)

CONTACT: Hester Kuipers

hkuipers@iavi.org

+31 20 5210343 / +31 64898130

Rachel Steinhardt

rsteinhardt@iavi.org

212-847-1045


'/>"/>
SOURCE International AIDS Vaccine Initiative
Copyright©2008 PR Newswire.
All rights reserved

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... 2017 Eyevensys, a private biotechnology ... gene expression technology that enables the safe, local, sustained ... a wide range of ophthalmic diseases, announces it has ... Regulatory Agency (MHRA) to advance its technology into clinical ... The ...
(Date:4/19/2017)... NEW YORK , April 19, 2017 The ... anticipated to showcase a healthy CAGR during the forecast period ... product type in the global digital mobile X-Ray devices market, ... 2,000 Mn in 2017, expanding at a CAGR of 7% ... create absolute $ opportunity of more than US$ 100 Mn ...
(Date:4/19/2017)... , April 19, 2017 The Global ... Forecast to 2022 report has covered and analysed the potential ... information on market size, shares and growth factors. The report ... challenges and opportunities in the global market. ... Browse 152 Tables and Figures, 6 Major ...
Breaking Medicine Technology:
(Date:4/25/2017)... ... ... The doctors at Wall Centre Dental are now expanding their practice by accepting ... receive dental care. The doctors offer three treatment options to put victims of ... at their dental office in Vancouver. Wall Centre Dental is currently welcoming even patients ...
(Date:4/25/2017)... ... April 25, 2017 , ... Patients who would ... results in a fraction of the time as traditional braces – Wilckodontics®. Dr. ... Specialists, now offers this revolutionary treatment with or without a referral. , ...
(Date:4/25/2017)... (PRWEB) , ... April 25, 2017 , ... ... the way in unveiling cutting-edge birth defects research related to Zika virus during ... the world’s premier society for this important science. , The Teratology ...
(Date:4/25/2017)... ... ... Buyers and sellers in the thriving multi-billion dollar cannabis marketplace – from ... be heartened by the industry’s current surge. But another thing that unifies them is ... At last they can simply, safely and effectively end their aroma anguish thanks to ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... predictive analytics to its patient care management module. Using this new feature, sleep ... patient has been initiated on continuous positive airway pressure (CPAP), oral, or other ...
Breaking Medicine News(10 mins):